Ligand Pharmaceuticals Inc (NAS:LGND)
$ 81.36 -1.01 (-1.23%) Market Cap: 1.46 Bil Enterprise Value: 1.16 Bil PE Ratio: 15.29 PB Ratio: 1.81 GF Score: 76/100

Ligand Pharmaceuticals Inc Extraordinary Shareholders Meeting Transcript

Dec 15, 2020 / 04:30PM GMT
Release Date Price: $60.64 (-4.47%)
Operator

Hello, and welcome to the Special Meeting of Stockholders of Ligand Pharmaceuticals Inc. Please note that today's meeting is being recorded. (Operator Instructions)

It is now my pleasure to turn today's meeting over to Charles Berkman, Senior Vice President, General Counsel and Secretary of Ligand Pharmaceuticals Incorporated. Mr. Berkman, the floor is yours.

Charles S. Berkman
Ligand Pharmaceuticals Incorporated - Senior VP, General Counsel & Secretary

Thank you. Welcome to Ligand's special meeting. I'm Charles Berkman, Ligand's General Counsel, and I will act as Chairman and Secretary for this meeting.

Due to the public health impact of the COVID-19 pandemic and to support the health and wellbeing of our stockholders, employees and their families, we are hosting this meeting in a virtual-only format. I hope everyone attending today's meeting and your families are safe and healthy.

I'd like to address 1 housekeeping matter before we begin. Registered stockholders or anyone who holds a valid proxy may submit comments or ask

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot